Allspring Global Investments Holdings, LLC
Position in EXEL — Exelixis, Inc.
CIK 1890906
CHARLOTTE, NC
Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$108,736,806
+$35,492,911 QoQ
Shares Held
1,998,471
+17.0% QoQ
Ownership
0.807%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#28
of 739 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 13%
Shared 0%
None 87%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Allspring Global Investments Holdings, LLC holds $767,651,533 across 75 Biotechnology names. EXEL ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
170,829 | $158,490,019 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
1,998,471 | $108,736,806 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
140,631 | $69,855,635 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
742,547 | $55,304,900 | |
| 5 | ASND |
Ascendis Pharma A/S
|
178,738 | $47,672,997 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
523,192 | $45,491,543 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69,700 | $43,460,737 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
67,668 | $36,334,331 |
All Filings in EXEL
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,736,806 | 1,998,471 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $73,243,895 | 1,707,715 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $60,652,830 | 1,383,820 | Shares | Other | 2026-01-15 | |
| 2025-09-30 | $48,228,982 | 1,167,772 | Shares | Other | 2025-10-20 | |
| 2025-06-30 | $55,538,242 | 1,259,942 | Shares | Other | 2025-07-25 | |
| 2025-03-31 | $59,433,298 | 1,609,786 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $52,040,905 | 1,562,790 | Shares | Other | 2025-01-29 | |
| 2024-09-30 | $22,265,202 | 858,004 | Shares | Defined | 2024-10-18 | |
| 2024-06-30 | $25,555,129 | 1,137,300 | Shares | Defined | 2024-07-26 | |
| 2024-03-31 | $30,348,533 | 1,278,910 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $33,106,703 | 1,380,021 | Shares | Defined | 2024-01-25 | |
| 2023-09-30 | $30,776,138 | 1,408,519 | Shares | Defined | 2023-10-27 | |
| 2023-06-30 | $38,267,697 | 2,002,496 | Shares | Defined | 2023-07-18 | |
| 2023-03-31 | $43,031,348 | 2,216,968 | Shares | Defined | 2023-04-13 | |
| 2022-12-31 | $28,521,508 | 1,778,149 | Shares | Defined | 2023-01-23 | |
| 2022-09-30 | $19,921,235 | 1,270,487 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $23,061,501 | 1,107,661 | Shares | Defined | 2022-07-25 | |
| 2022-03-31 | $25,305,567 | 1,116,258 | Shares | Other | 2022-05-02 | |
| 2021-12-31 | $10,698,644 | 585,265 | Shares | Defined | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||